Not Medicare Enrolled

Dr. Caroline Carter, MD

Family Medicine · Sugar Land, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
15200 SOUTHWEST FWY STE 175, Sugar Land, TX 77478
7134612915
In practice since 2009 (16 years)
NPI: 1366670820 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carter

Dr. Caroline Carter is a family medicine in Sugar Land, TX, with 16 years in practice. Based on federal Medicare data, Dr. Carter performed 1,139 Medicare services across 895 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carter received a total of $5,295 from 39 pharmaceutical and/or device companies across 321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 25% volume in TX$ $5,295 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,139
Medicare services
Top 25% in TX for family medicine
895
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Comprehensive metabolic blood panel161$10$31
Lipid panel (cholesterol and triglycerides)146$13$40
Office visit, established patient (30-39 min)137$83$292
Complete blood count (CBC) with differential123$8$20
Thyroid stimulating hormone (TSH) test104$16$50
Annual wellness visit, follow-up88$121$298
Hemoglobin A1c test (diabetes monitoring)85$9$25
Vitamin D level test84$29$60
Free thyroxine (T4) test40$9$20
Office visit, established patient (20-29 min)23$57$206
Flu vaccine, high-dose21$72$122
Flu vaccine administration21$31$50
Iron level test20$6$25
Transferrin (iron binding protein) level20$12$26
Ferritin level test (iron stores)19$13$28
Vitamin B-12 level test16$15$60
Annual depression screening16$18$43
Prostate cancer screening; prostate specific antigen test (psa)15$19$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,295
Total received (2018-2024)
Avg $756/year across 7 years
Top 12% in TX for family medicine
39
Companies
321
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,295 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$328
2023
$608
2022
$748
2021
$492
2020
$644
2019
$1,265
2018
$1,211

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$948
Abbott Laboratories
$764
AstraZeneca Pharmaceuticals LP
$418
Boehringer Ingelheim Pharmaceuticals, Inc.
$337
Merck Sharp & Dohme Corporation
$302
GlaxoSmithKline, LLC.
$292
PFIZER INC.
$262
SANOFI-AVENTIS U.S. LLC
$230
Amgen Inc.
$199
Astellas Pharma US Inc
$157
Takeda Pharmaceuticals U.S.A., Inc.
$155
AbbVie Inc.
$117
Biohaven Pharmaceutical Holding Company Ltd.
$104
OptiNose US, Inc.
$84
Lilly USA, LLC
$69
Janssen Pharmaceuticals, Inc
$68
Bayer HealthCare Pharmaceuticals Inc.
$64
Amarin Pharma Inc.
$62
Mylan Specialty L.P.
$58
Allergan, Inc.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47
SANOFI PASTEUR INC.
$46
Companion Medical, Inc.
$45
Medtronic USA, Inc.
$42
Esperion Therapeutics, Inc.
$42
Shire North American Group Inc
$37
Biohaven Pharmaceuticals, Inc.
$36
Phathom Pharmaceuticals, Inc.
$35
Sunovion Pharmaceuticals Inc.
$29
Sanofi Pasteur Inc.
$29
Kowa Pharmaceuticals America, Inc.
$28
Dexcom, Inc.
$25
Optinose US, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
Eisai Inc.
$19
Ironwood Pharmaceuticals, Inc
$18
Noden Pharma USA Inc
$14
Neos Therapeutics, LP
$14
Boston Scientific Corporation
$14
Top 3 companies account for 40.2% of total payments
Associated products mentioned in payments ›
AJOVY · ANORO · Adzenys XR-ODT · Aimovig · BELSOMRA · BEXSERO · BYDUREON · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Dayvigo · Dexcom G6 Transmitter · Dexilant · EUCRISA · EVENITY · FARXIGA · FASENRA · FIASP · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · General - Pain Management · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · LINZESS · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NURTEC ODT · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Proclaim Family of SCS IPGs · Prolia · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNCHROMED · Saxenda · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · Tresiba · Trintellix · UBRELVY · Utibron · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xhance · Xultophy 100/3.6 · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $465 per 100 Medicare services performed
Looking for a family medicine in Sugar Land?
Compare family medicines in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
1,412
Per 100K population
164.2
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Carter is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), and high industry engagement (low-engagement, top 12%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Carter experienced with comprehensive metabolic blood panel?
Based on Medicare claims data, Dr. Carter performed 161 comprehensive metabolic blood panel services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carter receive payments from pharmaceutical companies?
Yes. Dr. Carter received a total of $5,295 from 39 companies across 321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carter's costs compare to other family medicines in Sugar Land?
Dr. Carter's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →